Nov 21, 2024 1:41 PM
BACK TO TOP
KSE100
97,028.05
1481.60
(1.55%)
ALLSHR
61,794.66
612.49
(1.00%)
KSE30
30,105.02
527.02
(1.78%)
KMI30
145,811.27
1315.58
(0.91%)
BKTI
22,115.47
47.35
(0.21%)
OGTI
23,645.94
-16.55
(-0.07%)
KMIALLSHR
42,422.89
348.66
(0.83%)
PSXDIV20
37,689.52
477.50
(1.28%)
UPP9
29,419.21
789.32
(2.76%)
NITPGI
23,500.23
446.16
(1.94%)
NBPPGI
26,345.35
447.92
(1.73%)
MZNPI
19,371.64
218.22
(1.14%)
JSMFI
28,343.65
554.16
(1.99%)
ACI
15,061.99
80.52
(0.54%)
JSGBKTI
24,694.36
65.76
(0.27%)
MII30
13,715.34
140.96
(1.04%)
HBLTTI
15,183.43
01-11-2024
8.25
(0.05%)
The Searle Company Limited
PHARMACEUTICALS
Rs.82.30
-0.72
(-0.87%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Thu, Nov 21, 2024 1:39 PM
REG
FUT
ODL
Open
83.50
High
83.50
Low
81.04
Volume
2,456,281
CIRCUIT BREAKER
74.72 — 91.32
DAY RANGE
81.04 — 83.50
52-WEEK RANGE
43.03 — 89.45
Ask Price
82.40
Ask Volume
3,419
Bid Price
82.35
Bid Volume
495
LDCP
83.02
VAR
15.00
HAIRCUT
22.50
P/E Ratio (TTM) **
N/A
1-Year Change *
40.64%
YTD Change *
59.87%
Last update: Tue, Nov 5, 2024 4:00 PM
Open
0.00
High
0.00
Low
0.00
Close
71.86
Change
0.00%
LDCP
86.21
Volume
0
Total Trades
0
CIRCUIT BREAKER
77.59 — 94.83
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Thu, Nov 21, 2024 1:39 PM
Open
83.45
High
83.70
Low
81.66
Close
82.60
Change
-0.99%
LDCP
83.43
Volume
1,066,000
Total Trades
771
CIRCUIT BREAKER
75.09 — 91.77
DAY RANGE
81.66 — 83.70
Ask Price
82.76
Ask Volume
1,500
Bid Price
82.56
Bid Volume
1,000
Last update: Thu, Nov 21, 2024 1:35 PM
Open
83.00
High
83.00
Low
83.00
Close
83.00
Change
-1.43%
LDCP
84.20
Volume
1,500
Total Trades
2
CIRCUIT BREAKER
75.78 — 92.62
DAY RANGE
83.00 — 83.00
Ask Price
87.23
Ask Volume
1,000
Bid Price
83.05
Bid Volume
5,000

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

The Searle Company Limited was incorporated in Pakistan as a private limited company in October 1965. In November 1993, the Company was converted into a public limited company under the repealed Companies Ordinance, 1984 (now Companies Act, 2017). The Company is principally engaged in the manufacture of pharmaceutical and other consumer products. International Brands (Private) Limited is the Parent Company, which holds 56.32% shareholding in the Company.

KEY PEOPLE
Syed Nadeem AhmedCEO
Adnan Asdar AliChairperson
Zubair Razzak PalwalaCompany Secretary
ADDRESS

One IBL Centre 2nd Floor, Plot # 1, Block 7 & 8 D.M.C.H.S, Tipu Sultan Road Off Shahrah-e-Faisal, Karachi

WEBSITE

www.searlecompany.com

REGISTRAR

CDC Share Registrar Services Limited, CDC House, 99-B , Block B S.M.C.H.S Main Shahrah-e-Faisal, Karachi

AUDITOR

A. F. Ferguson & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
42,095,991.26
Shares
511,494,426
Free Float
255,747,212
Free Float
50.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 31, 2024 Transmission of Quarterly Report for the Period Ended 2024-09-30 View   PDF
Oct 30, 2024Financial Results for the Quarter Ended 2024-09-30 View   PDF
Oct 18, 2024Transmission of Annual Report for the Year Ended 2024-06-30 View   PDF
Oct 7, 2024Financial Results for the Year Ended 2024-06-30 View   PDF
May 3, 2024Transmission of Quarterly Report for the Period Ended 2024-03-31 View   PDF
Apr 30, 2024Financial Results for the Quarter Ended 2024-03-31 View   PDF
Mar 4, 2024Transmission of Quarterly Report for the Period Ended 2023-12-31 View   PDF
Mar 1, 2024Financial Results for the Quarter Ended 2023-12-31 View   PDF
Nov 1, 2023Transmission of Quarterly Report for the Period Ended 2023-09-30 View   PDF
Oct 27, 2023Financial Results for the Quarter Ended 2023-09-30 View   PDF
DateTitleDocument
Nov 18, 2024Notice of Extraordinary General Meeting View   PDF
Oct 29, 2024CERTIFIED TRUE COPY OF RESOLUTIONS PASSED AT 59TH ANNUAL GENERAL MEETING OF THE SEARLE COMPANY LIMITED View   PDF
Oct 23, 2024 Board Meeting View   PDF
Oct 18, 2024Notice of Annual General Meeting View   PDF
Sep 30, 2024 Board Meeting View   PDF
Jul 24, 2024Board Meeting Other Than Financial Results View   PDF
May 8, 2024Board Meeting Other Than Financial Results View   PDF
Apr 24, 2024Board Meeting View   PDF
Apr 9, 2024Board Meeting Other Than Financial Results View   PDF
Feb 22, 2024Board Meeting View   PDF
DateTitleDocument
Nov 19, 2024Corporate Briefing Session-2024 View   PDF
Oct 17, 2024Clarification/Denial of Fake News Regarding Alleged Interest in Acquiring Stake in Abbot Laboratories View   PDF
Oct 4, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Oct 4, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations
REVOKED
View   
Sep 4, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Sep 4, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations
REVOKED
View   
Aug 22, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Aug 19, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Aug 19, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Aug 15, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Jul 31, 2024Material Information View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2024202320222021
Sales25,827,21021,641,28217,737,28216,569,596
Profit after Taxation(3,330,859)302,1372,090,7172,122,924
EPS(6.95)0.755.367.01
Q1 2025Q3 2024Q2 2024Q1 2024
Sales6,677,6205,786,3615,752,7877,570,264
Profit after Taxation300,781(109,811)(103,548)324,635
EPS0.59(0.21)(0.22)0.80
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2024202320222021
Gross Profit Margin (%)48.6244.1048.7651.59
Net Profit Margin (%)(12.90)1.4011.7912.81
EPS Growth (%)(1,026.67)(86.01)(23.54)(37.69)
PEG0.01(0.59)(0.86)(0.92)

Payouts

DateFinancial ResultsDetailsBook Closure
August 8, 2023 2:36 PM- 31.13 AT A PREMIUM OF Rs.25/= PER SHARE (R) 21/08/2023 - 25/08/2023
May 25, 2023 3:46 PM- 31.13 AT A PREMIUM OF Rs.25/= PER SHARE (R) -
October 3, 2022 3:56 PM30/06/2022(YR) 25% (B) 22/10/2022 - 28/10/2022
October 4, 2021 3:40 PM30/06/2021(YR) 20% (D) - 30% (B) 08/11/2021 - 28/10/2021
October 28, 2020 2:51 PM30/09/2020(IQ) 13% AT A PREMIUM OF Rs.160/= PER SHARE (R) 19/11/2020 - 25/11/2020
September 29, 2020 3:41 PM30/06/2020(YR) 25%(F) (D) 22/10/2020 - 28/10/2020
October 1, 2019 11:11 AM30/06/2019(YR) 25%(F) (D) 19/10/2019 - 25/10/2019
October 12, 2018 10:30 AM30/06/2018(YR) 50% (D) - 15% (B) 16/11/2018 - 22/11/2018
September 29, 2017 10:50 AM30/06/2017(YR) 80% (D) - 20% (B) 21/10/2017 - 27/10/2017
February 27, 2017 4:29 PM31/12/2016(HYR) 20% (D) - 10% (B) 28/03/2017 - 04/04/2017

Financial Reports